Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Argus Health
Deloitte
McKesson
Johnson and Johnson
Boehringer Ingelheim
Accenture
Fuji

Generated: July 16, 2018

DrugPatentWatch Database Preview

ZIRGAN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Zirgan, and what generic alternatives are available?

Zirgan is a drug marketed by Bausch And Lomb and is included in one NDA.

The generic ingredient in ZIRGAN is ganciclovir. There are twenty-five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ganciclovir profile page.
Drug patent expirations by year for ZIRGAN
Medical Subject Heading (MeSH) Categories for ZIRGAN
Synonyms for ZIRGAN
106931-35-5
107910-75-8 (mono-hydrochloride salt)
2-?AMINO-?1,?9-?DIHYDRO-?9-?[[2-?HYDROXY-?1-?(HYDROXYMETHYL)ETHOXY]METHYL]-?6H-?PURIN-?6-?ONE
2-(2-Amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol
2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one
2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1,9-dihydro-6H-purin-6-one
2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one
2-amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-3,9-dihydro-6H-purin-6-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one
2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one
2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1H-purin-6-one
2-amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-3H-purin-6-one
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one
2-amino-9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}hydropurin-6-one
2-azanyl-9-[1,3-bis(oxidanyl)propan-2-yloxymethyl]-3H-purin-6-one
2'-NDG
2'-Nor-2'-deoxyguanosine
40034-EP2377510A1
410G320
6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-
82410-32-0
86357-12-2
9-((1,3-Dihydroxy-2-propoxy)methyl)guanine
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine
9-(1,3-dihydroxy-2-propoxymethyl)-guanine
9-(1,3-dihydroxy-2-propoxymethyl)guanine
9-(1,3-dihydroxy-2propoxymethyl)guanine
9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE
9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine
9-[[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine
96551-29-0
A840322
AB0012496
AB2000347
AC-8069
AC1L1FZ2
AC1Q52OB
ACT03317
AJ-08038
AK-76645
AKOS004119898
AKOS026749928
AN-14719
AN-5258
ANW-47031
BB_NC-1042
BBL029078
BDBM85707
BIDD:GT0783
Biolf 62
BIOLF-62
BPBio1_000877
BSPBio_000797
BW 759
BW 759U
BW-759U
BW-795
BW-B 759U
C07019
CAS_82410-32-0
CAS-82410-32-0
CCG-204629
CCRIS 9212
CHEBI:465284
CHEMBL182
Citovirax
CPD000058324
CS-2014
CTK8A1866
CTK8B5009
Cymevan
Cymeven
Cymevene
Cymevene (TN)
Cytovene
Cytovene (TN)
Cytovene IV
Cytovene-IV
D00333
D01LAP
D05ARP
DB01004
denosine
DR000714
DRG-0018
DSSTox_CID_21032
DSSTox_GSID_41032
DSSTox_RID_79613
DTXSID8041032
EC 627-054-3
EN300-49857
EU-0100539
FT-0611007
G 2536
G0315
GA2
ganciclovir
Ganciclovir (JAN/USP/INN)
Ganciclovir [USAN:INN:BAN:JAN]
Ganciclovir [USAN:USP:INN:BAN:JAN]
Ganciclovir & C34-dgA immunotoxin
Ganciclovir & D5-dgA immunotoxin
Ganciclovir, >=99% (HPLC), powder
Ganciclovir, 1.0 mg/mL (1% 1M HCl in Methanol), certified reference material
Ganciclovir, Antibiotic for Culture Media Use Only
Ganciclovir, European Pharmacopoeia (EP) Reference Standard
Ganciclovir, United States Pharmacopeia (USP) Reference Standard
Ganciclovirum
Ganciclovirum [Latin]
Gancyclovir
GCV & 1110U81
GCV & MSL
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody
HE054058
HE249231
HE300414
HE392556
HHEMG
HMS1570H19
HMS2090K08
HMS2097H19
HMS2235C21
HMS3259B13
HMS3261L19
HMS3371H01
HMS3604L19
HMS3655M18
HSDB 6512
HY-13637
Hydroxyacyclovir
I07-0010
IN1478
IRSCQMHQWWYFCW-UHFFFAOYSA-N
ISIS 2922 + Ganciclovir
J10127
KS-00000JPM
KS-1065
Lopac-G-2536
Lopac0_000539
LP00539
LS-73939
MB3795
MCULE-9512761592
MFCD00870588
MLS000028481
MLS001077349
MolPort-000-758-398
MolPort-002-507-301
MolPort-006-167-681
Natclovir
NC00647
NCGC00015471-01
NCGC00015471-02
NCGC00015471-03
NCGC00015471-04
NCGC00015471-05
NCGC00015471-06
NCGC00015471-08
NCGC00093928-01
NCGC00093928-02
NCGC00168567-01
NCGC00188980-01
NCGC00261224-01
NE60398
NSC_3454
NSC-759656
NSC759656
NU000232
Opera_ID_284
P9G3CKZ4P5
PDSP1_000816
PDSP2_000803
Pharmakon1600-01502362
Prestwick_1068
Prestwick0_000839
Prestwick1_000839
Prestwick2_000839
Prestwick3_000839
Q-201148
RS-21592
s1878
SAM002548936
SAM002589952
SBB066292
SC-12208
SCHEMBL14491348
SCHEMBL3033
SMP2_000038
SMR000058324
SPBio_002718
SR-01000075894
SR-01000075894-1
ST-605
STK801910
Tox21_110160
Tox21_110160_1
Tox21_500539
UNII-P9G3CKZ4P5
Virgan
Vitrasert
Vitrasert (TN)
Z1259084907
ZB000351
ZINC1505
Zirgan (TN)

US Patents and Regulatory Information for ZIRGAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb ZIRGAN ganciclovir GEL;OPHTHALMIC 022211-001 Sep 15, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Covington
Cipla
US Army
Farmers Insurance
Fuji
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.